**Core Concept**
Central anticholinergics, also known as anticholinergic agents or antimuscarinics, are a class of medications that block the action of acetylcholine in the central nervous system (CNS). They are primarily used to counteract the extrapyramidal side effects (EPS) of antipsychotic medications, such as parkinsonism and dystonia.

**Why the Correct Answer is Right**
Neuroleptic malignant syndrome (NMS) is a life-threatening neurological disorder caused by an adverse reaction to antipsychotic medications. It is characterized by fever, muscle rigidity, autonomic dysfunction, and altered mental status. Central anticholinergics are not used in the treatment of NMS, as they can actually worsen the condition by blocking the action of acetylcholine, which is involved in the regulation of body temperature and other autonomic functions. In contrast, the treatment of NMS typically involves stopping the offending medication, administering dantrolene, and providing supportive care.

**Why Each Wrong Option is Incorrect**
**Option A:** Akathisia is a type of EPS characterized by restlessness and agitation. Central anticholinergics are sometimes used to treat akathisia, as they can help to reduce muscle tension and improve motor function.
**Option B:** Parkinsonism is another type of EPS that can be caused by antipsychotic medications. Central anticholinergics are commonly used to treat parkinsonism, as they can help to improve motor function and reduce tremors.
**Option C:** Acute dystonia is a type of EPS characterized by sudden, involuntary muscle contractions. Central anticholinergics are often used to treat acute dystonia, as they can help to relax the affected muscles and improve motor function.

**Clinical Pearl / High-Yield Fact**
When using central anticholinergics to treat EPS, it's essential to weigh the potential benefits against the risks of adverse effects, such as dry mouth, constipation, and confusion. Additionally, central anticholinergics should be used judiciously in patients with certain medical conditions, such as glaucoma or urinary retention.

**✓ Correct Answer: D. Neuroleptic malignant syndrome**